From insulin to immunotherapies, clinical trials have powered some of the most important medical breakthroughs of our time.

When we think about treating bipolar I disorder (BD-I), the conversation often starts with pharmacotherapy as medication ...

Sidders discusses how integrating causality in AI for biotechnology can drive greater R&D success, and more generally about ...

The World Health Organization (WHO) has included Gilead Sciences' twice-yearly formulation of lenacapavir for pre-exposure ...

LEO is claiming global commercial rights to Spevigo for GPP, but will also collaborate with Boehringer on potential follow-up ...

Hengrui has reported topline data from the 301 study of their dual GLP-1 and GIP agonist HRS9531, administered as a ...

Reimbursement authority NICE has backed routine NHS use of Vertex's once-daily triple therapy Alyftrek ...

The UK Biobank has completed the world's largest whole body imaging project, compiling more than a billion scans from 100,000 ...

The Market Access for CNS Therapeutics Summit is the only dedicated forum focused on tackling the unique commercial and ...